Alaunos Therapeutics, Inc. (TCRT)
1.50
-0.06
(-3.85%)
USD |
NASDAQ |
Sep 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Alaunos Therapeutics Total Assets (Quarterly) : 1.516M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.516M |
| March 31, 2026 | 1.883M |
| December 31, 2025 | 2.966M |
| September 30, 2025 | 3.724M |
| June 30, 2025 | 4.735M |
| March 31, 2025 | 2.12M |
| December 31, 2024 | 2.755M |
| September 30, 2024 | 3.55M |
| June 30, 2024 | 4.678M |
| March 31, 2024 | 6.037M |
| December 31, 2023 | 8.263M |
| September 30, 2023 | 19.44M |
| June 30, 2023 | 27.93M |
| March 31, 2023 | 48.64M |
| December 31, 2022 | 64.94M |
| September 30, 2022 | 67.34M |
| June 30, 2022 | 73.93M |
| March 31, 2022 | 84.99M |
| December 31, 2021 | 94.86M |
| September 30, 2021 | 113.76M |
| June 30, 2021 | 106.76M |
| March 31, 2021 | 128.47M |
| December 31, 2020 | 146.34M |
| September 30, 2020 | 165.89M |
| June 30, 2020 | 181.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 198.28M |
| December 31, 2019 | 109.11M |
| September 30, 2019 | 117.95M |
| June 30, 2019 | 73.17M |
| March 31, 2019 | 83.50M |
| December 31, 2018 | 95.05M |
| September 30, 2018 | 66.80M |
| June 30, 2018 | 76.38M |
| March 31, 2018 | 87.46M |
| December 31, 2017 | 105.61M |
| September 30, 2017 | 116.56M |
| June 30, 2017 | 126.81M |
| March 31, 2017 | 94.49M |
| December 31, 2016 | 106.35M |
| September 30, 2016 | 117.12M |
| June 30, 2016 | 128.01M |
| March 31, 2016 | 141.68M |
| December 31, 2015 | 153.72M |
| September 30, 2015 | 173.36M |
| June 30, 2015 | 124.04M |
| March 31, 2015 | 131.65M |
| December 31, 2014 | 45.24M |
| September 30, 2014 | 49.11M |
| June 30, 2014 | 55.35M |
| March 31, 2014 | 63.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.864M |
| Shareholders Equity (Quarterly) | 0.652M |
| Current Ratio | 0.7708 |